On February 4, the pharmaceutical group, had been indicted for “aggravated tort of deceit “and” involuntary injury”.
The Sanofi group has been under investigation for “involuntary homicide” in the survey on the marketing of the anti-epileptic Depakine open in 2016, confirming information of the daily Le Monde, announced the company on Monday. Last February, the pharmaceutical company had already been indicted for “aggravated tort of deceit “and” involuntary injury”.
The investigation, opened in September 2016, was intended to establish whether there had been a deception “about the risks inherent in the use of the product and the precautions to be taken to render its use dangerous to the health of the human being”, and covered the period from 1990 to April 2015.
The group challenged the prosecution
The molecule in question, sodium valproate, has been marketed since 1967 under the brand name Depakine by Sanofi, but also under generic brands, and is prescribed for individuals suffering from a bipolar disorder. It presents a high risk of birth defects on the fetus if taken by a pregnant woman. The number of children with disabilities due to the sodium valproate, a molecule present in the Depakine and used against epilepsy and bipolar disorder, is estimated to be between 15 and 30 000, according to the studies.
summer Offer : Take advantage of the special offer 2 months for 1€ I subscribe
READ ALSO >> Sanofi: toxic waste, but “since when?”
The group claims to have “complied with its disclosure obligations and disputes the propriety of these proceedings”. “The laboratory has entered the chamber of the instruction in order to challenge his indictment. All of these elements does not prejudge the responsibility of the laboratory”, does it before.
Read our complete file
Sanofi
Sanofi ensures that France is “at the centre” of its strategy, Sanofi wants to remove a thousand jobs in France, a plan “shameful” for the unions Vaccine against the Covid-19 : Sanofi would not be part of the 5 candidates selected by Trump
last July, the justice had for the first time recognised the responsibility of the State, as well as Sanofi and doctors, in the devastating effects of the anti-epileptic Depakine, condemning him to indemnify the families of severely disabled children.
